Background
Syncope may be a warning sign of potentially life-threatening cardiac disease in children; therefore, promptly identifying its underlying cause is clinically important. Hypertrophic cardiomyopathy (HCM) is an important cardiac cause of syncope in children. An abnormal blood pressure response (aBPR) is less recognized as a potential mechanism of syncope in patients with HCM.
Children with HCM who experience an aBPR and syncope typically present with evident myocardial hypertrophy. Pediatric HCM presenting with an aBPR and restrictive physiological features despite the absence of overt hypertrophy on conventional echocardiography is rarely described. We report a child who presented with recurrent exercise-induced syncope despite the absence of overt hypertrophy on initial conventional echocardiography.
Ultimately, the integration of the clinical presentation, subtle cardiac magnetic resonance (CMR) abnormalities, exercise-induced aBPR, restrictive physiological features, and a pathogenic MYH7 variant supported the diagnosis of HCM.
Case presentation
A 12-year-old girl experienced recurrent syncope while running, occurring multiple times over a year, sometimes thrice weekly. There was no family history of HCM or sudden cardiac death. Physical examination on admission was unremarkable.
Routine laboratory tests, including blood glucose, serum electrolytes, and troponin, were normal, as were cranial computed tomography (CT) and an upright tilt-table test. Since the syncope was always triggered by exercise, a cardiovascular cause was considered first. Echocardiography (Figure 1A-D) showed no overt left ventricular hypertrophy, with an interventricular septal thickness at end-diastole (IVSd) of 9.5 mm, a left ventricular posterior wall thickness at end-diastole (LVPW) of 6.1 mm, and a left atrial (LA) diameter of 23 mm.
Left ventricular systolic function was preserved, while mildly impaired diastolic function was suggested by an early-to-late diastolic transmitral velocity ratio (E/A) of 2.3 and an early diastolic mitral inflow velocity to early diastolic mitral annular velocity ratio (E/e′) of 9.25. Coronary computed tomography angiography (CTA) (Figure 1E) showed no abnormalities in coronary artery origin, course, or diameter. CMR (Figure 1F) demonstrated mild focal thickening and late gadolinium enhancement (LGE) in the basal and mid anterior interventricular septal regions, with a maximum thickness of 11.0 mm.
Resting electrocardiogram (ECG) showed sinus rhythm with no abnormal Q waves, ST-segment changes, or T wave abnormalities (Figure 2A). However, signs of myocardial ischemia were observed on the exercise ECG (Figure 2B) and the child experienced prodromal symptoms, including dizziness and chest tightness during exercise. The ECGs and echocardiograms of her parents were also normal.
On the basis of these findings, the underlying etiologies for recurrent syncope in this patient was definitely-related to cardiovascular diseases, but the culprit remained to be uncovered since the mild local thickening of the myocardium on CMR as well as the slightly increased ratio of E/e and E/A on echocardiography could not explain the child’s severe symptoms. After multidisciplinary discussion, cardiac catheterization was performed to completely rule out the coronary artery abnormalities and obtain invasive hemodynamic parameters. The catheterization showed no coronary anomalies, with elevated left ventricular (LV) diastolic pressure but no obvious left ventricular outflow tract (LVOT) pressure gradient [LV:103/16 (mean, 58) mmHg, aortic pressure: 97/66 (mean, 81) mmHg].
After isoproterenol infusion, significant ST-segment depression was also noted, but LVOT pressure gradient showed no changes [LV:95/0 (mean, 43) mmHg, aortic pressure: 89/39 (mean, 58) mmHg]. After coronary artery abnormalities had been excluded, the elevated LV diastolic pressure and subtle myocardial abnormalities on CMR raised the suspicion of an atypical cardiomyopathy, and genetic testing was subsequently performed. Trio-based improved whole-exome sequencing identified a heterozygous MYH7 variant, NM_000257.4:c.2302G>A (p.Gly768Arg), in the proband.
The clinical genetic laboratory classified this variant as pathogenic according to the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) framework, based on the evidence combination PS2, PP1_Strong, PS4_Moderate, PM1, PM2, and PP3. Sanger sequencing confirmed the heterozygous variant in the proband, whereas both parents and her younger sister were wild type at this locus. The variant was therefore considered apparently de novo, although parental germline mosaicism could not be completely excluded.
The variant was absent from the Genome Aggregation Database (gnomAD) and has been reported in patients with hypertrophic or restrictive cardiomyopathy. A previous report described the same MYH7 c.2302G>A (p.Gly768Arg) variant in monozygotic twins with HCM (1). The affected residue is highly conserved, and multiple computational tools predict a deleterious effect (2).
Although HCM was diagnosed, the mechanism of recurrent syncope remained uncertain because marked myocardial hypertrophy, LVOT obstruction, ventricular tachycardia, and extensive LGE were absent. A review of the literature identified an aBPR as a potential hemodynamic mechanism of syncope in HCM, although it has been reported mainly in patients with overt structural abnormalities. Stress echocardiography was therefore performed to evaluate the blood pressure response to exercise.
During exercise, ST-segment depression and reductions in systolic blood pressure (SBP), diastolic blood pressure (DBP), and stroke volume (SV) occurred, accompanied by an increase in LV filling pressure (E/e′ =12.5), with the abnormalities peaking at 5–6 minutes. The reductions in blood pressure and SV persisted during recovery (Figure 2C), without exercise-induced wall-motion abnormalities. These findings supported the presence of an aBPR.
Reassessment of the catheterization data also showed that aortic pressure decreased from 97/66 (mean, 81) mmHg to 89/39 (mean, 58) mmHg following isoproterenol infusion, further suggesting impaired hemodynamic reserve. After navigating through layers of uncertainty, the patient was ultimately diagnosed with atypical HCM accompanied by an aBPR and restrictive physiological features. Individualized management included exercise restriction, propranolol (10 mg three times daily), and enalapril (5 mg once daily).
At the most recent follow-up, more than 1 year after treatment initiation, the patient remained asymptomatic and free of recurrent syncope while continuing the same medication doses.
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Declaration of Helsinki and its subsequent amendments. Written informed consent was obtained from the guardian of the patient for publication of this study and accompanying images. A copy of the written consent is available for review by the editorial office of this journal.
Discussion
We report an unusual pediatric case of HCM with severe clinical symptoms but without overt hypertrophy on conventional echocardiography, in which an aBPR and restrictive physiological features contributed to the exercise-induced syncope. This unusual presentation of pediatric HCM, with severe symptoms but only subtle myocardial abnormalities on CMR, raises important diagnostic and management considerations. First, in children with recurrent exercise-induced syncope, an aBPR should be evaluated even when conventional echocardiography shows no overt hypertrophy; when cardiomyopathy remains clinically suspected, genetic testing may provide additional diagnostic evidence.
Second, HCM exhibits significant phenotypic variability, and HCM with restrictive physiological features is even rarer (3). In individuals carrying a pathogenic HCM-associated variant, particularly when overt hypertrophy is absent, exercise testing may help identify functional abnormalities such as an aBPR; however, this finding should be interpreted as part of a comprehensive clinical risk assessment rather than as an isolated predictor of sudden cardiac death.
A previous multicenter study of pediatric HCM reported that 28% of patients exhibited an abnormal exercise response, including an aBPR, exercise-induced ischemic electrocardiographic changes, or ventricular ectopy (4). Abnormal exercise responses were associated with more severe septal hypertrophy, larger left atrial dimensions, higher resting LVOT gradients, and lower transplant-free survival, supporting the clinical value of exercise testing in pediatric HCM (4). As for our case, despite the severity and frequency of clinical symptoms, the phenotype of cardiomyopathy was not apparent, which hindered the initial assessment.
However, evaluation of the aBPR and restrictive physiological phenotype during exercise and drug loading provided key clues for the final diagnosis. The diagnostic odyssey of this patient highlights the indispensable, multi-dimensional, and interlocking role of medical imaging in navigating atypical presentations of pediatric cardiomyopathy. In pediatric cardiology, a diagnosis should not rely solely on genetic screening; even when a pathogenic variant is identified—such as the heterozygous MYH7 c.2302G>A (p.Gly768Arg) variant in this case—the genotype alone may not fully explain the clinical severity when overt hypertrophy is absent on conventional echocardiography.
A meticulous, phenotype-driven diagnostic approach remains paramount. Within this clinical reasoning process, different imaging modalities provided sequential, complementary insights. Conventional echocardiography initially showed no overt left ventricular hypertrophy (IVSd: 9.5 mm; LVPW: 6.1 mm), thereby helping to exclude a classic hypertrophic phenotype.
Subsequent coronary CTA further excluded congenital coronary artery anomalies, which are common alternative causes of pediatric exercise-induced syncope. The true breakthrough relied on the integration of high-resolution morphological and functional stress imaging. CMR effectively unveiled subtle focal thickening (11.0 mm) and LGE in the anterior interventricular septum, providing the first objective physical evidence of myocardial fibrosis to support the suspicion of an atypical cardiomyopathy and justify the genetic analysis.
Ultimately, exercise stress echocardiography dynamically captured an acute reduction in SV and a concomitant increase in LV filling pressure (E/e' =12.5) during peak exercise. This real-time functional imaging evidence demonstrated the underlying restrictive physiological phenotype and acute hemodynamic instability. Thus, multi-modality imaging successfully bridged the gap between a perplexing clinical presentation and a genetic finding, transforming the diagnostic dilemma into a clear, actionable management strategy and directly guiding targeted therapeutic interventions.
The blood pressure response to exercise is determined by the interaction among cardiac output, heart rate (HR), SV, and systemic vascular resistance (SVR). Several mechanisms may contribute to an aBPR in HCM (5). First, inappropriate peripheral vasodilation may cause an excessive reduction in SVR.
Second, impaired diastolic filling, myocardial fibrosis, or limited contractile reserve may prevent an appropriate increase in SV during exercise (6). Third, elevated LV filling pressure and myocardial ischemia may further impair cardiac output. Dynamic LVOT obstruction and exercise-induced arrhythmias can also contribute in some patients, although neither was observed in this case.
In our patient, the simultaneous reduction in blood pressure and SV, elevation of E/e′, and exercise-induced ST-segment depression suggest that impaired LV filling and myocardial ischemia limited the cardiac output response during exercise. The persistence of a reduced SV during recovery further supports impaired hemodynamic reserve. Clinically, an aBPR may help identify pediatric patients with HCM who require closer assessment and follow-up, but it should be interpreted together with symptoms, imaging findings, arrhythmias, and other established risk markers rather than used as an isolated prognostic indicator.
Supplementary